Polysaccharide Vaccine

A category of vaccines that use the extracted and purified outer polysaccharide coat of the particular bacteria.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
051019742017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Life-threatening Streptococcus pneumoniae infections often occur after hematopoietic stem cell transplant (HSCT… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND Persons with human immunodeficiency virus (HIV) infection are at increased risk of pneumococcal disease. We evaluated… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2014
Highly Cited
2014
On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal… (More)
Is this relevant?
2014
2014
BACKGROUND Elderly people do not mount strong immune responses to vaccines. We compared 23-valent capsular polysaccharide (23vPPV… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Although thymus-independent type 2 antigens generally do not undergo Ig class switching from IgM to IgG, pneumococcal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
PURPOSE The purpose of this study was to determine whether active immunization against pneumolysin (PLY), or polysaccharide… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
We performed a double-blind, randomized, controlled phase I study to assess safety, immunogenicity, and antibody persistence of… (More)
Is this relevant?
2004
2004
The 23-valent pneumococcal polysaccharide vaccine (PPV) has been available for a number of years and is recommended for high-risk… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2001
2001
Background: The current study evaluated the reactogenicity and immunogenicity of Typherix™,1 arecently developed Vi… (More)
  • table I
  • table II
  • table III
Is this relevant?
1995
1995
ABSTRACT: Anti-pneumococcal IgM, IgG1, IgG2, and IgA antibody titers were determined in 61 pediatric patients with recurrent… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?